Incyte Corporation
Status: Publicly traded
Direct answer
Incyte Corporation is publicly traded on NASDAQ under the ticker INCY.
Incyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. Its current product offerings include JAKAFI, prescribed for myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that targets oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor utilized for...
Can you invest in Incyte Corporation?
Yes. Incyte Corporation trades publicly on NASDAQ as INCY.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Incyte Corporation
Detailed equity research is provided by MarketSnap.